These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 12559600

  • 1. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis.
    Vanizor Kural B, Orem A, Cimşit G, Yandi YE, Calapoglu M.
    Clin Chim Acta; 2003 Feb; 328(1-2):71-82. PubMed ID: 12559600
    [Abstract] [Full Text] [Related]

  • 2. The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease.
    Orem A, Yandi YE, Vanizor B, Cimşit G, Uydu HA, Malkoç M.
    Clin Biochem; 2002 May; 35(3):217-24. PubMed ID: 12074830
    [Abstract] [Full Text] [Related]

  • 3. Dyslipidaemia & oxidative stress in patients of psoriasis: Emerging cardiovascular risk factors.
    Asha K, Singal A, Sharma SB, Arora VK, Aggarwal A.
    Indian J Med Res; 2017 Dec; 146(6):708-713. PubMed ID: 29664028
    [Abstract] [Full Text] [Related]

  • 4. The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status.
    Orem C, Orem A, Uydu HA, Celik S, Erdöl C, Kural BV.
    Coron Artery Dis; 2002 Feb; 13(1):65-71. PubMed ID: 11917201
    [Abstract] [Full Text] [Related]

  • 5. The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis.
    Orem A, Cimşit G, Değer O, Orem C, Vanizor B.
    Clin Chim Acta; 1999 Jun 15; 284(1):81-8. PubMed ID: 10437645
    [Abstract] [Full Text] [Related]

  • 6. Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients.
    Vanizor Kural B, Orem A, Cimşit G, Uydu HA, Yandi YE, Alver A.
    Clin Chim Acta; 2003 Jun 15; 332(1-2):23-30. PubMed ID: 12763276
    [Abstract] [Full Text] [Related]

  • 7. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, Figueiredo A, Teixeira F, Castro E, Rocha-Pereira P, Santos-Silva A.
    Am J Clin Dermatol; 2010 Dec 01; 11(6):423-32. PubMed ID: 20429617
    [Abstract] [Full Text] [Related]

  • 8. Age-related modification of antioxidant enzyme activities in relation to cardiovascular risk factors.
    Fabian E, Bogner M, Elmadfa I.
    Eur J Clin Invest; 2012 Jan 01; 42(1):42-8. PubMed ID: 21722101
    [Abstract] [Full Text] [Related]

  • 9. Lipoprotein peroxidation in adult psoriatic patients.
    Offidani AM, Ferretti G, Taus M, Simonetti O, Dousset N, Valdiguie P, Curatola G, Bossi G.
    Acta Derm Venereol Suppl (Stockh); 1994 Jan 01; 186():38-40. PubMed ID: 8073834
    [Abstract] [Full Text] [Related]

  • 10. [Oxidized LDL and lipids as risk factors for ischemic heart disease in type 2 diabetes].
    Zamaklar M, Lalić K, Rajković N, Trifunović D, Dragasević M, Popović L, Drasković D, Laić N, Jotić A, Vasović O, Lukić L, Milicić T, Potpara T.
    Vojnosanit Pregl; 2005 Jan 01; 62(7-8):529-36. PubMed ID: 16171015
    [Abstract] [Full Text] [Related]

  • 11. Erythrocyte antioxidant enzyme activities and lipid peroxidation in patients with types IIb and IV hyperlipoproteinemias.
    Efe H, Kirci D, Deger O, Yildirmis S, Uydu HA, Orem C.
    Tohoku J Exp Med; 2004 Mar 01; 202(3):163-72. PubMed ID: 15065642
    [Abstract] [Full Text] [Related]

  • 12. Lipid peroxidation markers in Crohn's disease: the associations and diagnostic value.
    Boehm D, Krzystek-Korpacka M, Neubauer K, Matusiewicz M, Paradowski L, Gamian A.
    Clin Chem Lab Med; 2012 Mar 03; 50(8):1359-66. PubMed ID: 22868800
    [Abstract] [Full Text] [Related]

  • 13. Accumulation of oxidized low-density lipoprotein in psoriatic skin and changes of plasma lipid levels in psoriatic patients.
    Tekin NS, Tekin IO, Barut F, Sipahi EY.
    Mediators Inflamm; 2007 Mar 03; 2007():78454. PubMed ID: 17497039
    [Abstract] [Full Text] [Related]

  • 14. Study of changes in antioxidant enzymes status in diabetic post menopausal group of women suffering from cardiovascular complications.
    Kumawat M, Sharma TK, Singh N, Ghalaut VS, Vardey SK, Sinha M, Kaushik GG.
    Clin Lab; 2012 Mar 03; 58(3-4):203-7. PubMed ID: 22582492
    [Abstract] [Full Text] [Related]

  • 15. [Correlations between lipid ratio/oxidative stress status in COPD patients and pulmonary hypertension 
as well as prognosis].
    Li C, Yan L, Xu J.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov 28; 41(11):1168-1174. PubMed ID: 27932762
    [Abstract] [Full Text] [Related]

  • 16. Decreased neutrophil antioxidative enzyme activities and increased lipid peroxidation in hyperlipoproteinemic human subjects.
    Efe H, Değer O, Kirci D, Karahan SC, Orem A, Calapoğlu M.
    Clin Chim Acta; 1999 Jan 28; 279(1-2):155-65. PubMed ID: 10064127
    [Abstract] [Full Text] [Related]

  • 17. Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer.
    Badid N, Ahmed FZ, Merzouk H, Belbraouet S, Mokhtari N, Merzouk SA, Benhabib R, Hamzaoui D, Narce M.
    Pathol Oncol Res; 2010 Jun 28; 16(2):159-67. PubMed ID: 19731090
    [Abstract] [Full Text] [Related]

  • 18. Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men.
    Porkkala-Sarataho E, Nyyssönen K, Salonen JT.
    Atherosclerosis; 1996 Jul 28; 124(1):83-94. PubMed ID: 8800496
    [Abstract] [Full Text] [Related]

  • 19. Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04.
    Zhang C, Li J, Wang J, Song X, Zhang J, Wu S, Hu C, Gong Z, Jia L.
    BMC Complement Altern Med; 2017 Aug 14; 17(1):403. PubMed ID: 28806986
    [Abstract] [Full Text] [Related]

  • 20. [The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia].
    Broncel M, Koter-Michalak M, Chojnowska-Jezierska J.
    Przegl Lek; 2006 Aug 14; 63(9):738-42. PubMed ID: 17479860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.